Junwei Su
Impact in
- Infectious Diseases top 1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
- General Dentistry top 10%
Papers in
-
- COVID-19 Clinical Research Studies 11
- SARS-CoV-2 and COVID-19 Research 6
- Oncology 10
- Cancer Immunotherapy and Biomarkers 3
- Lung Cancer Research Studies 2
- Co-authors
- Kaijin Xu (9 shared papers)Yunqing Qiu (4 shared papers)Xingjiang Hu (1 shared paper)Hangping Yao (1 shared paper)Yan Lou (1 shared paper)Lin Liu (1 shared paper)Qingwei David Zhao (1 shared paper)Xi Yang (1 shared paper)
- Journals
- Pathogens (3 papers)Lung Cancer (2 papers)Journal of Inflammation Research (2 papers)PLoS ONE (2 papers)BMC Infectious Diseases (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Junwei Su
52 papers receiving 2.2k citations
Junwei Su's Hit Papers
Peers
Comparison fields: 5 of 116
- Infectious Diseases 1.3k
- General Dentistry 10
- Neurology 160
- Modeling and Simulation 49
- Oncology 180
Countries citing papers authored by Junwei Su
This map shows the geographic impact of Junwei Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junwei Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junwei Su more than expected).
Fields of papers citing papers by Junwei Su
This network shows the impact of papers produced by Junwei Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junwei Su. The network helps show where Junwei Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Junwei Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms Hit paper breakdown → | 2020 | 1017 |
| 2 | 2020 | 382 | |
| 3 | 2020 | 164 | |
| 4 | Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study Hit paper breakdown → | 2023 | 147 |
| 5 | 2021 | 70 | |
| 6 | 2011 | 57 | |
| 7 | 2021 | 56 | |
| 8 | 2016 | 45 | |
| 9 | 2022 | 40 | |
| 10 | 2022 | 33 | |
| 11 | 2014 | 32 | |
| 12 | 2020 | 30 | |
| 13 | 2013 | 24 | |
| 14 | 2023 | 18 | |
| 15 | 2020 | 14 | |
| 16 | 2022 | 14 | |
| 17 | 2018 | 10 | |
| 18 | 2020 | 10 | |
| 19 | 2021 | 8 | |
| 20 | 2021 | 8 |
About Junwei Su
Junwei Su is a scholar working on Infectious Diseases, Oncology, Pulmonary and Respiratory Medicine, Hepatology and Epidemiology, having authored 55 papers that have together received 2.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (12 papers), COVID-19 Clinical Research Studies (11 papers), SARS-CoV-2 and COVID-19 Research (6 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Nerve injury and regeneration (2 papers), Advanced Graph Neural Networks (2 papers) and Lung Cancer Research Studies (2 papers). The work is most often cited by research in Infectious Diseases (1.3k citations), General Dentistry (10 citations), Neurology (160 citations), Modeling and Simulation (49 citations) and Oncology (180 citations). Junwei Su has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Kaijin Xu, Yunqing Qiu, Xingjiang Hu, Hangping Yao, Yan Lou, Lin Liu, Qingwei David Zhao, Xi Yang, Xiaoyang Lu and Lingjuan He. Their work appears in journals such as Pathogens, Lung Cancer, Journal of Inflammation Research, PLoS ONE and BMC Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.